ASSESSING THE ABILITY OF THE EQ-5D-5L TO CAPTURE LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPACTS OF HEREDITARY ANGIOEDEMA ATTACKS

Orladeyo (berotralstat) - BioCryst Pharmaceuticals

https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-2026/poster-session-1-4/assessing-the-ability-of-the-eq-5d-5l-to-capture-long-term-health-related-quality-of-life-impacts-of-hereditary-angioedema-attacks

Lena Hubig, PhD 1; Adam Gordois, MSc 2; Patrick Gillard, DPharm 3; Sandra Nestler-Parr, MPhil, MSc, PhD 4; Andrew Lloyd, DPhil 5; Andrew Briggs, DPhil 6; Tom Booth, PhD 5

Mar 6, 2026